Leveraging Real-Time Clinical Data to Deliver Certainty in Formulation Development: Case Studies from Across 300 Delivered Programs - Paris, France

Paris, France | 12 March 2025
Overview

Optimizing Drug Products Using Translational Pharmaceutics® RapidFACT®. 

Find out more about this application of the Translational Pharmaceutics® platform for drug product optimization at our upcoming event series this year. 

Drug product optimization is a critical development step that is common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles, to transition from an early development formulation to one suitable for chronic administration in patients, or as part of a life-cycle management strategy. 

Traditional drug product optimization processes take 12-18 months to complete and place significant emphasis on the predictive power of laboratory and preclinical assessments. This approach is a non-optimal working model necessitated by the multiple disciplines required to develop, make and test new formulations in humans.

In this presentation, Dr Andrew Parker will describe the application of Quotient Sciences’ Translational Pharmaceutics to re-engineer and streamline the drug product optimization process, using clinical data to improve decision-making and halve development timelines.

Learning Objectives:

  • Develop an understanding of Translational Pharmaceutics when applied to drug product optimization
  • Hear case studies on reformulation programs
Date/AgendaLocation

March 12th, 2025

Registration:  5.30pm – 6pm  

Seminar/Talk: 6pm - 7pm  

Networking Drinks: 7pm - 9pm   

MELIA PARIS VENDOME Hotel

8 Rue Cambon, 75001 Paris, France 

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register now
Location
MELIA PARIS VENDOME Hotel
8 Rue Cambon, 75001
Paris, France

Meet our experts:

We look forward to meeting at Basel.

Dr. Andrew Parker

Senior Drug Development Consultant

Dr. Andrew Parker has over two decades of experience in the pharmaceutical industry, spanning from preclinical development, throug...

About Andrew